Quarterly report pursuant to Section 13 or 15(d)

Note 11 - Operating Segments (Tables)

Note 11 - Operating Segments (Tables)

9 Months Ended

Sep. 30, 2014

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Segment Reporting for the Quarter Ended September 30, 2014
	Treatment			Services		Segments Total			Corporate ⁽¹⁾			PF Medical S.A. ⁽¹⁾			Consolidated Total
Revenue from external customers	$	12,705		$	4,200	$	16,905		$	—			—		$	16,905
Intercompany revenues		—			19		19			—			—			—
Gross profit		4,943			638		5,581			—			—			5,581
Interest income	—				—		—			7			—			7
Interest expense		(10	)		—		(10	)		(128	)		—			(138	)
Interest expense-financing fees		—			—		—			(52	)		—			(52	)
Depreciation and amortization		748			213		961			12			—			973
Segment profit (loss)		3,985			10		3,995			(1,422	)		(229	)		2,344
Expenditures for segment assets		3			39		42			—			—			42

Segment Reporting for the Quarter Ended September 30, 2013
	Treatment			Services			Segments Total			Corporate ⁽¹⁾			PF Medical S.A. ⁽¹⁾		Consolidated Total
Revenue from external customers	$	8,929		$	10,143		$	19,072		$	—			—	$	19,072
Intercompany revenues		82			11			93			—			—		—
Gross profit		1,801			1,328			3,129			—			—		3,129
Interest income		—			—			—			8			—		8
Interest expense		(10	)		(1	)		(11	)		(241	)		—		(252	)
Interest expense-financing fees		—			—			—			(40	)		—		(40	)
Depreciation and amortization		999			248			1,247			20			—		1,267
Segment profit (loss)		616			387			1,003			(1,571	)		—		(568	)
Expenditures for segment assets		192			6			198			—			—		198

Segment Reporting for the Nine Months Ended September 30, 2014
	Treatment			Services			Segments Total			Corporate ⁽¹⁾			PF Medical S.A. ⁽¹⁾			Consolidated Total
Revenue from external customers	$	29,773		$	10,333		$	40,106		$	—			—		$	40,106
Intercompany revenues		—			64			64			—			—			—
Gross profit		6,379			853			7,232			—			—			7,232
Interest income		—			—			—			20			—			20
Interest expense		(35	)		(1	)		(36	)		(469	)		—			(505	)
Interest expense-financing fees		—			2			2			(135	)		—			(133	)
Depreciation and amortization		2,535			709			3,244			38			—			3,282
Segment profit (loss)		2,977			(1,981	)		996			(4,302	)		(414	)		(3,720	)
Expenditures for segment assets		334			41			375			—			—			375

Segment Reporting for the Nine Months Ended September 30, 2013
	Treatment			Services			Segments Total			Corporate ⁽¹⁾			PF Medical S.A. ⁽¹⁾		Consolidated Total
Revenue from external customers	$	26,379		$	35,306		$	61,685		$	—			—	$	61,685
Intercompany revenues		1,149			66			1,215			—			—		—
Gross profit		3,968			3,722			7,690			—			—		7,690
Interest income		—			—			—			27			—		27
Interest expense		(38	)		3			(35	)		(562	)		—		(597	)
Interest expense-financing fees		—			—			—			(87	)		—		(87	)
Depreciation and amortization		3,063			708			3,771			72			—		3,843
Segment profit (loss)		524			(432	)		92			(4,528	)		—		(4,436	)
Expenditures for segment assets		367			6			373			—			—		373

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details